logo/base Created with Sketch.
logo echosens
chevron Validate
logo echosens
  • FibroScan® chevron
    • Discover FibroScan®
    • New FibroScan® GO
    • FibroScan® Expert 630
    • FibroScan® Compact 530
    • FibroScan® Mini+ 430
  • Scores chevron
    • Discover Scores
    • Fast™
    • Agile 3+
    • Agile 4
    • myFibroScan
  • Pharma chevron
    • Clinical Trials
    • White Paper
  • Liver health chevron
    • Understand liver health
    • NAFLD / NASH
    • Alcoholic liver disease
    • Viral Hepatitis
  • Users chevron
    • Essentials for users
    • Examination procedure
    • Covid-19
    • Probe and machine disinfection
    • Users testimonials
    • echosensacademy.com
  • Patients chevron
    • Information for patients
    • Find a FibroScan®
    • myliverexam.com
  • About us chevron
    • Discover Echosens
    • Working at Echosens
    • Environmental, Social and Governance
    • Locate us
en
  • Français
chevron Contact
Menu
  • chevron FibroScan®
    • chevron Discover FibroScan®
    • chevron New FibroScan® GO
    • chevron FibroScan® Expert 630
    • chevron FibroScan® Compact 530
    • chevron FibroScan® Mini+ 430
  • chevron Scores
    • chevron Discover Scores
    • chevron Fast™
    • chevron Agile 3+
    • chevron Agile 4
    • chevron myFibroScan
  • chevron Pharma Solutions
    • chevron Clinical Trials
    • chevron White Paper
  • chevron Clinical evidence
    • chevron Discover the section
    • chevron Clinical Library
    • chevron EASL Guidelines - 2021
    • chevron Baveno VII - 2021
    • chevron AACE Guidelines - 2022
    • chevron AASLD Guidance – 2023
  • chevron Liver health
    • chevron Understand liver health
    • chevron NAFLD / NASH
    • chevron Alcoholic liver disease
    • chevron Viral Hepatitis
  • chevron Users
    • chevron Essentials for users
    • chevron Examination procedure
    • chevron Covid-19
    • chevron Users testimonials
    • chevron Probe and machine disinfection
    • chevron echosensacademy.com
  • chevron Patients
    • chevron Information for patients
    • chevron Find a FibroScan®
    • chevron myliverexam.com
  • chevron Resources
    • chevron Blog and news
    • chevron Educational Videos
  • chevron About us
    • chevron Discover Echosens
    • chevron Working at Echosens
    • chevron ESG
    • chevron Patents
    • chevron Trademarks
    • chevron Locate us
  • chevron Contact us
  • chevron Support
English version chevron
  • Français
Change region
chevron Back
Article | 18.01.2023

We are shaping the future of liver health- Laurent Sandrin on CNEWS

Watch the interview of Laurent Sandrin, Chairman and Chief Science and Technology Officer, in “Le Rendez-vous de l’Innovation” on CNEWS.
By Agence Delta
 
Echosens was born in 2001 from Laurent Sandrin’s thesis work at the ESPCI’s Waves and Acoustics Laboratory. Thanks to the development of the concept of impulse elastography, this doctoral student in physics succeeded in measuring the elasticity of soft media. Working with doctors at the Institut Mutualiste Montsouris, Laurent Sandrin decided to apply his invention to the evaluation of the hardness of the liver, which can be used to predict the health of the organ. Following the first clinical trials, the first FibroScan® was put on the market in 2003.
 
 
>> Watch the full interview (with ENG subtitles) <<
 
 
 

 

chevron Original Article

Article | 19.04.2022

World Liver Day – April 19th 2022

Article | 09.07.2021

Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic

Press Release | 15.12.2021

Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary

  • ©2023 Echosens

  • Legal notice
  • Privacy notice
  • GCS
  • Locate us
  • chevron Support